NCT07530666 2026-04-15
Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia
Dartsbio Pharmaceuticals Ltd.
Phase 1/2 Not yet recruiting
Clinical Trials
11 trialsNCT07519564 2026-04-09
A Phase I Clinical Study to Evaluate the PK, PD, Efficacy, and Safety of GB18 Injection in Patients With Tumor Cachexia
Kexing Biopharm Co., Ltd.
Phase 1 Not yet recruiting
NCT06989437 2026-04-08
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Pfizer
Phase 2/3 Recruiting
NCT06736275 2026-04-03
A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors
Jiangsu Nutai Biologics Co., Ltd
Phase EARLY_PHASE1 Completed
NCT07112196 2026-03-30
VINCIT
CatalYm GmbH
Phase 2/3 Recruiting
NCT07356037 2026-01-21
Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 3 Not yet recruiting
NCT05865535 2026-01-08
A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia
AVEO Pharmaceuticals, Inc.
Phase 1 Recruiting
NCT06937177 2025-12-12
Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy
Endevica Bio
Phase 2 Recruiting
NCT07168226 2025-09-11
Phase 2 Cachexia Clinical Trial to Evaluate the Efficacy and Safety of ASCA101
MetaFines
Phase 2 Not yet recruiting
NCT06898255 2025-06-05
A Phase I Study to Evaluate GFS202A in Advanced Solid Tumor Patients With Pre-cachexia or Cachexia
Genfleet Therapeutics (Shanghai) Inc.
Phase 1 Recruiting
NCT05546476 2025-05-31
PROACC-1
Pfizer
Phase 2 Completed